Scholarly Activity

Publications:

  1. Evoy KE, Morrison M, Saklad SR.  Pregabalin and gabapentin abuse: a systematic review.  Drugs 2017; DOI 10.1007/s40265-017-0700-x. (ePub ahead of print)
  2. Raber H, Evoy KE, Lim L.  Anti-inflammatory and antipyretic analgesics and drugs used in gout.  In:  Side Effects of Drugs Annual. Vol. 38.  Ray S, ed.  SEDA, United Kingdom: Elsevier; 2016. Pages 77-86.
  3. Evoy KE, Wong A, Simon S.  A cautionary tale for the physician:  case report and review of food dependent-exercise-induced anaphylaxis.  Gen Int Med Clin Innov 2016;1(4):56-58.
  4. Evoy KE, Raber H, Battjes E, Sheridan E.  Volunteering at diabetes camp:  experience from the pharmacy residents’ perspective. Curr Pharm Teach and Learn 2016;8(3):437-441.
  5. Vogeler T, McClain C, Evoy KE.  Bupropion and varenicline combination therapy for smoking cessation:  a systematic review.  Am J Drug Alcohol Abuse 2016;42(2):129-39.
  6. Raber H, Ali A, Dethloff A, Evoy KE, Helmen J, Lim L, Nguyen D Sheridan E. Anti-inflammatory and antipyretic analgesics and drugs used in gout. In: Side Effects of Drugs Annual. Vol. 37. Ray S, ed. United Kingdom: Elsevier; 2015.
  7. Evoy KE, Malone K, Gonzalvo J, Sheehan A, Ramsey D, Sprunger T. Benefits and challenges of implementing a mentoring program into a pharmacy teaching and learning curriculum (TLC). Am J Health Syst Pharm 2015;72:906-909.
  8. Evoy KE, Mably M, Fischer J. Lessons in developing ambulatory pharmacist positions under financial constraints. Am J Health Syst Pharm 2015;72:1350-1353.
  9. Patel KV, Aspesi AV, Evoy KE. Suvorexant: newly approved for the treatment of insomnia. Ann Pharmacother 2015;49:477-483.
  10. Evoy KE, Look K, Margolis A. Statistics Review Part 6: Bias in Randomized Controlled Trials. JPSW 2014;17:19-21.
  11. Evoy KE. North A. 2013 Pharmacy Residency Cheese Curd Crawl: a scientific approach to critiquing fine cuisine. JPSW 2014;17:5-9.
  12. Evoy KE, Abel SR. Ranibizumab: the first vascular endothelial growth factor inhibitor approved for the treatment of diabetic macular edema. Ann Pharmacother 2013;47(6):811-8.
  13. Evoy KE, Abel SR. Aflibercept: newly approved for the treatment of macular edema following central retinal vein occlusion. Ann Pharmacother 2013;47(6):819-27.

Professional Posters:

  1. Groff L, Britt RS, Lee GC, Reveles KR, Boyd NK, Evoy KE, Frei CR. Comparative-effectiveness of ceftaroline and daptomycin as first-line therapy for patients with infective endocarditis infections admitted to hospitals in the United States Veterans Health Care System.  Texas Pharmacy Day at the Capitol in Austin, TX.  February 2017.  (encore)
  2. Kitten A, Lee H, Blevins T, Taylor A, Evoy KE. SAMM Pharmacy Project.  University of Texas Health Science Center San Antonio Community Service Learning Conference in San Antonio, TX.  January 2017.
  3. Mootz ML, Britt RS, Mootz A, Evoy KE, Frei CR. Association of ceftaroline with mortality and re-hospitalization among patients with pneumonia admitted to the United States Veterans Health Care System.  ASHP Midyear Clinical Meeting in Las Vegas, NV.  December 2016.
  4. Dean TA, Evoy KE, Britt RS, Mootz ML, Frei CR. Comparative-Effectiveness of Ceftaroline and Daptomycin as First-line Therapy for Patients with Diabetic Foot Infections Admitted to Hospitals in the United States Veterans Health Care System.  ASHP Midyear Clinical Meeting in Las Vegas, NV.  December 2016.
  5. Kitten A, Morrison M, Hallowell S, Saklad S, Evoy KE. Abuse and misuse of pregabalin and gabapentin: a systematic review.  ASHP Midyear Clinical Meeting in Las Vegas, NV.  December 2016.
  6. Groff L, Britt RS, Lee GC, Reveles KR, Boyd NK, Evoy KE, Frei CR. Comparative-effectiveness of ceftaroline and daptomycin as first-line therapy for patients with infective endocarditis infections admitted to hospitals in the United States Veterans Health Care System.  ACCP Annual Meeting in Hollywood, FL.  October 2016.
  7. Britt RS, Lee GC, Reveles KR, Boyd NK, Evoy KE, Frei CR. Comparative-Effectiveness of Ceftaroline and Daptomycin as First-line Therapy for Patients with Skin and Soft Tissue Infections Admitted to Hospitals in the United States Veterans Health Care System.   ID Week Conference in New Orleans, LA.  October 2016.
  8. Mootz ML, Britt RS, Lee GC, Reveles KR, Boyd NK, Evoy KE, Frei CR. Comparative-Effectiveness of Ceftaroline and Daptomycin as First-line Therapy for Patients with Bacteremia or Sepsis Admitted to Hospitals in the United States Veterans Health Care System.    ID Week Conference in New Orleans, LA.  October 2016.
  9. Evoy KE, Campbell K, Battjes E. 3-Year Outcomes of a Pharmacist-Run, Diabetes Education and Management Program.  AADE Conference in San Diego, CA.  August 2016.
  10. McClain C, Vogeler T, Evoy KE. Combination bupropion SR and varenicline for smoking cessation: a systematic review.  University of Texas Research Day in Austin, TX.  April 2016.
  11. Evoy K, Battjes E. Development and Implementation of a Pharmacist Transitions of Care Service.  ASHP Midyear Clinical Meeting in Anaheim, CA.  December 2014.
  12. Battjes E, Evoy K, Raber H, Schultz T. Pharmacist-Managed, Patient-Centered Diabetes Education Program.  Trinity Health/CHE National Clinical Summit in Chicago, IL.  October 2014.
  13. Evoy K. Justification and Implementation of an Ambulatory Oncology Pharmacy Practice.  UHC Conference in Orlando, FL.  December 2013.
  14. Evoy K. Diabetes in China:  New Epidemic, Ancient Treatments.  ASHP Midyear Clinical Meeting in Las Vegas, NV.  December 2012.

Facebook link iconMake a Gift
Texas Pharmacy: The University of Texas at Austin College of Pharmacy